Anika Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Anika Therapeutics, Inc. (ANIK) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.10 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2024-03-15
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-09-30 was 500.00K shares, a 66.67% increase year-over-year.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 700.00K shares, a 133.33% increase year-over-year.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-03-31 was 600.00K shares, a 100.00% increase year-over-year.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-09-30 was 300.00K shares, a 50.00% increase year-over-year.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 1.10M shares.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2012 was 131.27K shares, a 88.51% decline from fiscal 2011.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2011 was 1.14M shares, a 5.63% decline from fiscal 2010.
- Anika Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2010 was 1.21M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | 1.10M shares 10-K · filed 2024-03-15 | ||||||
| 2021-09-30 | 1.10M shares 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | 1.10M shares 10-Q · filed 2022-08-04 | ||||||
| 2017-09-30 | 500.00K shares 10-Q · filed 2017-10-27 | 600.00K shares 10-Q · filed 2017-10-27 | |||||
| 2017-06-30 | 700.00K shares 10-Q · filed 2017-07-28 | 0.70 shares 10-Q · filed 2017-07-28 | |||||
| 2017-03-31 | 600.00K shares 10-Q · filed 2017-05-04 | ||||||
| 2016-09-30 | 300.00K shares 10-Q · filed 2017-10-27 | 400.00K shares 10-Q · filed 2017-10-27 | |||||
| 2016-06-30 | 300.00K shares 10-Q · filed 2017-07-28 | 0.30 shares 10-Q · filed 2017-07-28 | 300.00K shares 10-Q · filed 2016-08-01 | ||||
| 2016-03-31 | 300.00K shares 10-Q · filed 2017-05-04 | ||||||
| 2015-09-30 | 200.00K shares 10-Q · filed 2016-11-01 | 230.88K shares 10-Q · filed 2015-11-03 | 200.00K shares 10-Q · filed 2016-11-01 | 215.72K shares 10-Q · filed 2015-11-03 | |||
| 2015-06-30 | 200.00K shares 10-Q · filed 2016-08-01 | 238.47K shares 10-Q · filed 2015-08-04 | 200.00K shares 10-Q · filed 2016-08-01 | 207.84K shares 10-Q · filed 2015-08-04 | |||
| 2015-03-31 | 100.00K shares 10-Q · filed 2016-05-03 | 133.38K shares 10-Q · filed 2015-05-04 | |||||
| 2014-09-30 | 122.97K shares 10-Q · filed 2015-11-03 | 118.72K shares 10-Q · filed 2015-11-03 | |||||
| 2014-06-30 | 67.82K shares 10-Q · filed 2015-08-04 | 113.30K shares 10-Q · filed 2015-08-04 | |||||
| 2014-03-31 | 87.13K shares 10-Q · filed 2015-05-04 | ||||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-06 | 88.28K shares 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | 469.62K shares 10-Q · filed 2014-08-04 | 459.97K shares 10-Q · filed 2014-08-04 | |||||
| 2013-03-31 | 555.00K shares 10-Q · filed 2014-05-05 | ||||||
| 2012-12-31 | 131.27K shares 10-K · filed 2013-03-14 | ||||||
| 2012-09-30 | 133.06K shares 10-Q · filed 2013-11-05 | 104.19K shares 10-Q · filed 2013-11-05 | |||||
| 2012-06-30 | 99.25K shares 10-Q · filed 2013-08-06 | 126.12K shares 10-Q · filed 2013-08-06 | |||||
| 2012-03-31 | 380.55K shares 10-Q · filed 2013-05-06 | ||||||
| 2011-12-31 | 1.14M shares 10-K · filed 2013-03-14 | ||||||
| 2011-09-30 | 1.67M shares 10-Q · filed 2012-11-08 | 1.06M shares 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | 1.15M shares 10-Q · filed 2012-08-07 | 1.09M shares 10-Q · filed 2012-08-07 | |||||
| 2010-12-31 | 1.21M shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |